First Human Trial of HIV Vaccine Produced Immune Response in 97% of Volunteers
[ad_1] A phase 1 clinical trial of an experimental vaccine primed the immune system using a unique approach to prevent HIV. The promising results, announced in February by the International AIDS Vaccine Initiative (IAVI) and Scripps Research, demonstrated that the vaccine was successful in stimulating the production of rare immune cells necessary to generate antibodies…